Default company panoramic image


Enabling Personalized Cancer Treatments and Chemotherapy Drug Screening

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Huntington, WV, USA
  • Currency USD
  • Founded April 2010
  • Employees 4
  • Website

Company Summary

Current cancer treatments destroy the cells that form the bulk of the tumor, but are largely ineffective against the root of the cancer, the cancer stem cells (CSC). Our Novel ChemoID® assay allows various available standard of care chemotherapy drugs and their combination to be tested for efficacy against the cancer stem cells as well as the bulk of tumors for enabling personalized cancer treatment.


  • Default avatar
    Pier Paolo Claudio, MD., Ph.D.

    Dr. Pier Paolo Claudio has 25 years of scientific laboratory management experience. He brings to Cordgenics the blend of knowledge, experience, relationships and energy needed to initiate operations, build the strong foundation and corporate culture and lead the company to achieve rapid growth. Dr. Claudio is a pioneer in cancer research and has developed effective treatments targeted directly at cancer cells. The real ground breaking aspect of h

  • Default avatar
    Jagan V Valluri, Ph.D.
    Chief Operating Officer

    Dr. Valluri has over 21 years of research experience in cell culture technology, production of anticancer bio-molecules. His current efforts focus on mammalian cell culture medium development and optimization, and novel cell expression systems for production of therapeutic proteins. Dr. Valluri will play a crucial role in advancing medical research and provide leadership toward the achievement of our mission, strategy, and annual goals and object